Zobrazeno 1 - 1
of 1
pro vyhledávání: '"521"'
Autor:
Shen J; GSK, Avenue Fleming, 20 1300, Wavre, Belgium.; Present address: Takeda Pharmaceutical Company Limited, Zurich, Switzerland., Begum N; GSK, Freelance C/O GSK, Wavre, Belgium., Ruiz-Garcia Y; GSK, Rockville, USA., Martinon-Torres F; Genetics, Vaccines and Infections Research Group (GENVIP), Instituto de Investigación Sanitaria de Santiago, University of Santiago, Santiago de Compostela, Spain.; Department of Pediatrics, Translational Pediatrics and Infectious Diseases, Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Respiratorias (CIBERES), Madrid, Spain., Bekkat-Berkani R; GSK, Rockville, USA., Meszaros K; GSK, Avenue Fleming, 20 1300, Wavre, Belgium. KINGA.H.MESZAROS@GSK.COM.
Publikováno v:
BMC public health [BMC Public Health] 2022 May 31; Vol. 22 (1), pp. 1078. Date of Electronic Publication: 2022 May 31.